Kiora Pharmaceuticals Inc (KPRX) stock
KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
$0.93−0.05 (-5.30%)
Close on Nov 17, 2026Market cap $4.11MP/E –Yield –
Kiora Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Kiora Pharmaceuticals's operating margin for the twelve months ending Mar 31, 2025 was -55210.8%. For fiscal 2024 it was 28.2%, against -56960.5% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 28.2% | +56988.7 |
| FY2020 | Dec 31, 2020 | -56960.5% | −56304.3 |
| FY2018 | Dec 31, 2018 | -656.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | -12724.4% | −11714.0 |
| Q1 FY2024 | Mar 31, 2024 | 82.6% | +1238.9 |
| Q4 FY2020 | Dec 31, 2020 | -9698.8% | −9481.7 |
| Q1 FY2019 | Mar 31, 2019 | 30.9% | +5573.5 |
| Q3 FY2018 | Sep 30, 2018 | -1010.5% | +1233.0 |
| Q2 FY2018 | Jun 30, 2018 | -1156.3% | +425.9 |
| Q1 FY2018 | Mar 31, 2018 | -217.1% | +1014.1 |
| Q3 FY2017 | Sep 30, 2017 | -5542.6% | – |
| Q2 FY2017 | Jun 30, 2017 | -2243.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -1582.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -1231.2% | – |
See a number that looks wrong?